References

1. Harlow SD et al. STRAW 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012 Apr;19(4):387-95

2. Menopause Foundation of Canada. https://menopausefoundationcanada.ca/menopause-in-canada-report/

3. Whiteley J, DiBonaventura M, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health Nov 2013;22(11):983-90.

4. Menopause Foundation of Canada. Menopause and Work in Canada 2023. https://menopausefoundationcanada.ca/pdf_files/Menopause_Work_Canada_2023EN.pdf

5. Santoro N. Understanding the menopause journey. Climacteric 2025:1-5.

6. Davis SR, Taylor S, Hemachandra C, et al. The 2023 Practitioner's Toolkit for Managing Menopause. Climacteric 2023;26(6):517-536.

7. Archer DF, Sturdee DW, Baber R, et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011;14(5):515-28.

8. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531-9.

9. Schaedel Z, Holloway D, Bruce D, Rymer J. Management of sleep disorders in the menopausal transition. Post Reprod Health. 2021;27(4):209-214.

10. Shea AK, Wolfman W, Fortier M, Soares CN. Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. J Obstet Gynaecol Can. 2021;43(11):1316-1323 e1. doi:10.1016/j.jogc.2021.08.009

11. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001;163(3 Pt 1):608-13.

12. Horst K, Cirino N, Adams KE. Menopause and mental health. Current opinion in obstetrics & gynecology. Apr 1 2025;37(2):102-110.

13. Harlow SD, Gold EB, Hood MM, Mukwege AA, Randolph JF, Greendale GA. Abnormal uterine bleeding is associated with fatigue during the menopause transition. Menopause. Mar 11 2025;doi:10.1097/GME.0000000000002525

14. Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA 2023;329(5):405-420.

15. Johnston S, Bouchard C, Fortier M, Wolfman W. Guideline No. 422b: Menopause and Genitourinary Health. J Obstet Gynaecol Can. Nov 2021;43(11):1301-1307 e1.

16. Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric 2024;27(5):466-472.

17. ESHRE Guideline on Premature Ovarian Insufficiency 2024. https://www.imsociety.org/education/updated-eshre-premature-ovarian-insufficiency-clinical-guideline/?v=5435c69ed3bc

18. Duralde ER, Sobel TH, Manson JE. Management of perimenopausal and menopausal symptoms. BMJ 2023;382:e072612.

19. Yuksel N, Evaniuk D, Huang L, et al. Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. J Obstet Gynaecol Can 2021;43(10):1188-1204 e1.

20. Khan AA, Alrob HA, Ali DS, Dandurand K, Wolfman W, Fortier M. Guideline No. 422g: Menopause and Osteoporosis. J Obstet Gynaecol Can. May 2022;44(5):527-536 e5.

21. The Nonhormone Therapy Position Statement of The North American Menopause Society" Advisory P. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause 2023;30(6):573-590.

22. Lega IC, Fine A, Antoniades ML, Jacobson M. A pragmatic approach to the management of menopause. CMAJ May 15 2023;195(19):E677-E672.